APA (7th ed.) Citation

EG, W., S, K., D, F., J, H., C, H., S, M., . . . T, H. (2024). Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine. Vaccines, 12(9), . https://doi.org/10.3390/vaccines12090965

Chicago Style (17th ed.) Citation

EG, Wee, et al. "Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine." Vaccines 12, no. 9 (2024). https://doi.org/10.3390/vaccines12090965.

MLA (9th ed.) Citation

EG, Wee, et al. "Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine." Vaccines, vol. 12, no. 9, 2024, https://doi.org/10.3390/vaccines12090965.